Drugs / SPARC1310
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01940146 | Oct → Dec 2014 | seasonal allergic rhinitis | Sun Pharma Advanced Research Company Limited | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPARC1310 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01940146 ↗ |
| Known as | S0597 | “S0597 is a novel glucocorticosteroid that was formulated as an intranasal spray to treat seasonal allergic rhinitis (SAR).” PMID 27613466 ↗ Sep 2016 |